ACPU
IBB icon

Arrowgrass Capital Partners (US)’s iShares Biotechnology ETF IBB Stock Holding History

Arrowgrass Capital Partners (US)’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-4,308
Closed -$479K – 538
2017
Q3 		$479K Sell
4,308
-4,053
-48% -$433K ﹤0.01% 522
2017
Q2 		$864K Sell
8,361
-9,750
-54% -$960K 0.01% 530
2017
Q1 		$1.77M Buy
18,111
+834
+5% +$79.8K 0.02% 438
2016
Q4 		$1.53M Buy
17,277
+14,376
+496% +$1.31M 0.02% 394
2016
Q3 		$280K Buy
+2,901
New +$276K ﹤0.01% 419

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
CM
Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Arrowgrass Capital Partners (US)'s IBB Position: Q4 2017 in Review

Arrowgrass Capital Partners (US) sold out of iShares Biotechnology ETF (IBB) in Q4 2017, closing a stake of 4,308 shares — an estimated $479K sold.

Arrowgrass Capital Partners (US) first reported a position in IBB in Q3 2016 and held it in 5 quarters. The position peaked at $1.77M in Q1 2017. 624 funds tracked by Wall St. Rank hold IBB as of Q4 2017.

  • Arrowgrass Capital Partners (US) reported no remaining iShares Biotechnology ETF position as of Q4 2017 after selling out during the quarter.
  • Arrowgrass Capital Partners (US) sold 4,308 iShares Biotechnology ETF shares in Q4 2017, an estimated $479K.
  • Arrowgrass Capital Partners (US) first reported a position in iShares Biotechnology ETF in Q3 2016 and held it in 5 quarters.
  • Arrowgrass Capital Partners (US)'s iShares Biotechnology ETF position peaked at $1.77M in Q1 2017.
  • 624 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2017.

Based on Arrowgrass Capital Partners (US)'s 13F filing for Q4 2017, filed 14 Feb 2018.